Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
BJOG ; 129(5): 796-803, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34800331

ABSTRACT

OBJECTIVE: To determine the characteristics and outcomes of pregnancy in women with Turner syndrome. DESIGN: Retrospective 20-year cohort study (2000-20). SETTING: Sixteen tertiary referral maternity units in the UK. POPULATION OR SAMPLE: A total of 81 women with Turner syndrome who became pregnant. METHODS: Retrospective chart analysis. MAIN OUTCOME MEASURES: Mode of conception, pregnancy outcomes. RESULTS: We obtained data on 127 pregnancies in 81 women with a Turner phenotype. All non-spontaneous pregnancies (54/127; 42.5%) were by egg donation. Only 9/31 (29%) pregnancies in women with karyotype 45,X were spontaneous, compared with 53/66 (80.3%) pregnancies in women with mosaic karyotype 45,X/46,XX (P < 0.0001). Women with mosaic karyotype 45,X/46,XX were younger at first pregnancy by 5.5-8.5 years compared with other Turner syndrome karyotype groups (P < 0.001), and more likely to have a spontaneous menarche (75.8% versus 50% or less, P = 0.008). There were 17 miscarriages, three terminations of pregnancy, two stillbirths and 105 live births. Two women had aortic dissection (2.5%); both were 45,X karyotype with bicuspid aortic valves and ovum donation pregnancies, one died. Another woman had an aortic root replacement within 6 months of delivery. Ten of 106 (9.4%) births with gestational age data were preterm and 22/96 (22.9%) singleton infants with birthweight/gestational age data weighed less than the tenth centile. The caesarean section rate was 72/107 (67.3%). In only 73/127 (57.4%) pregnancies was there documentation of cardiovascular imaging within the 24 months before conceiving. CONCLUSIONS: Pregnancy in women with Turner syndrome is associated with major maternal cardiovascular risks; these women deserve thorough cardiovascular assessment and counselling before assisted or spontaneous pregnancy managed by a specialist team. TWEETABLE ABSTRACT: Pregnancy in women with Turner syndrome is associated with an increased risk of aortic dissection.


Subject(s)
Turner Syndrome , Cesarean Section , Cohort Studies , Female , Humans , Pregnancy , Pregnancy Outcome/epidemiology , Retrospective Studies , Turner Syndrome/complications , Turner Syndrome/epidemiology , Turner Syndrome/genetics , United Kingdom/epidemiology
2.
J Endocrinol Invest ; 39(2): 227-33, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26100530

ABSTRACT

OBJECTIVE: Blepharophimosis syndrome (BPES) is an autosomal dominant genetic condition resulting from heterozygous mutations in the FOXL2 gene and clinically characterized by an eyelid malformation associated (type I) or not (type II) with premature ovarian failure. The distinction between the two forms is critical for female patients, as it may allow to predict fertility and to plan an appropriate therapy. Identifying an underlying causative mutation is not always predictive of the clinical type of BPES since genotype-phenotype correlations are not yet fully delineated. Here, we describe the clinical and hormonal phenotypes of three female patients with BPES type 1 from two novel families, correlate their phenotypes with identified mutations, and investigate the effects of hormone replacement therapy (HRT). METHODS: Clinical, biochemical, and genetic evaluation were undertaken in all the patients and genotype-phenotype correlation was analyzed. The effects of substitutive hormonal therapy on secondary sexual characteristics development and induction of menarche were evaluated. RESULTS: All patients presented with primary amenorrhea or other signs of ovarian dysfunction. Two distinct mutations, a missense p.H104R change and an in-frame p.A222_A231dup10 duplication in the FOXL2 gene were identified. Observed phenotypes were not in accordance with the prediction based on the current genotype-phenotype correlations. HRT significantly improved secondary sexual characteristics development, as well as the induction of menarche. CONCLUSIONS: This study highlights the importance of early recognition of BPES and emphasizes the need of personalized therapy and follow-up in female patients carrying distinct FOXL2 mutations.


Subject(s)
Amenorrhea/etiology , Blepharophimosis/genetics , Forkhead Transcription Factors/genetics , Gene Duplication , Mutation, Missense , Ovary/physiopathology , Primary Ovarian Insufficiency/etiology , Skin Abnormalities/genetics , Urogenital Abnormalities/genetics , Adult , Amenorrhea/prevention & control , Amino Acid Substitution , Blepharophimosis/drug therapy , Blepharophimosis/physiopathology , Blepharophimosis/surgery , Combined Modality Therapy , DNA Mutational Analysis , Eyelids/abnormalities , Female , Forkhead Box Protein L2 , Genetic Association Studies , Hormone Replacement Therapy , Humans , Italy , Menarche/drug effects , Ovary/drug effects , Pedigree , Primary Ovarian Insufficiency/prevention & control , Skin Abnormalities/drug therapy , Skin Abnormalities/physiopathology , Skin Abnormalities/surgery , Urogenital Abnormalities/drug therapy , Urogenital Abnormalities/physiopathology , Urogenital Abnormalities/surgery , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL